In conclusion, the characterization of the role of histamine, H4R receptor and GILZ could pave the way for innovative therapies for various chronic inflammatory diseases (allergy, asthma, chronic itch, intestinal disorders) and autoimmune diseases (arthritis. Here, TSC22D3 is linked to autoimmune disease.